We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

248 hedge funds and large institutions have $1.51B invested in Amneal Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 97 increasing their positions, 73 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

33% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 73

31% more capital invested

Capital invested by funds: $1.16B → $1.51B (+$354M)

30% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 30

3% more funds holding

Funds holding: 241 → 248 (+7)

2.44% more ownership

Funds ownership: 45.57% → 48.01% (+2.4%)

Holders
248
Holders Change
+7
Holders Change %
+2.9%
% of All Funds
3.25%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
39
Increased
97
Reduced
73
Closed
30
Calls
$6.94M
Puts
–
Net Calls
+$6.94M
Net Calls Change
+$5.71M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$17.4M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$12.6M
3
WW
Westshore Wealth
California
+$12.4M
4
Allspring Global Investments
Allspring Global Investments
North Carolina
+$9.53M
5
Morgan Stanley
Morgan Stanley
New York
+$9.03M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$15.4M
2
BCP
BlackBarn Capital Partners
New York
-$11.3M
3
JP Morgan Chase
JP Morgan Chase
New York
-$5.04M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$3.59M
5
HF
HRT Financial
New York
-$3.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
251
Jennison Associates
New York
– -$635K -78,548 Closed
Simplex Trading
252
Simplex Trading
Illinois
– -$633K -70,527 Closed
EC
253
EntryPoint Capital
New York
– -$490K -60,573 Closed
DS
254
DRW Securities
Illinois
– -$473K -58,446 Closed
CC
255
Centiva Capital
New York
– -$465K -57,471 Closed
SSA
256
Schonfeld Strategic Advisors
New York
– -$435K -53,771 Closed
Amundi
257
Amundi
France
– -$388K -46,392 Closed
OQS
258
Occudo Quantitative Strategies
Florida
– -$365K -45,143 Closed
XT
259
XTX Topco
Cayman Islands
– -$274K -33,918 Closed
CIM
260
Contravisory Investment Management
Massachusetts
– -$254K -31,454 Closed
GCM
261
Graham Capital Management
Connecticut
– -$208K -25,681 Closed
SPA
262
Sherbrooke Park Advisers
New York
– -$180K -22,300 Closed
WWM
263
Whalen Wealth Management
Nevada
– -$135K -16,741 Closed
State of Tennessee, Department of Treasury
264
State of Tennessee, Department of Treasury
Tennessee
– -$133K -16,397 Closed
CC
265
Corton Capital
Ontario, Canada
– -$126K -15,542 Closed
I
266
InceptionR
California
– -$115K -14,191 Closed
1C
267
111 Capital
France
– -$115K -14,166 Closed
SSG
268
Summit Securities Group
New York
– -$32K -3,955 Closed
Group One Trading
269
Group One Trading
Illinois
– -$26.8K -2,991 Closed
BIG
270
Brooklyn Investment Group
New York
– -$12.8K -1,579 Closed
CIAS
271
CBIZ Investment Advisory Services
Ohio
– -$809 -100 Closed
FDCDDQ
272
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$809 -100 Closed
GWM
273
Geneos Wealth Management
Colorado
– -$550 -68 Closed
CIAM
274
Caitong International Asset Management
Hong Kong
– -$210 -26 Closed
KG
275
Kilter Group
New York
– -$178 -22 Closed
8 9 10
11
12

AMRX Hedge Fund Activity: Q3 2025 in Review

248 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q3 2025, worth a combined $1.51B — up 31% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new AMRX positions and 30 closed out — a net gain of 9 holders — while 97 added to existing stakes and 73 trimmed.

The largest buyer was BlackRock, adding an estimated $17.4M. The largest seller was Millennium Management, cutting an estimated $15.4M.

  • 248 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q3 2025, up from 241 in Q2 2025.
  • Funds reported $1.51B of Amneal Pharmaceuticals stock for Q3 2025, up 31% quarter-over-quarter.
  • 39 funds opened new Amneal Pharmaceuticals positions in Q3 2025 and 30 closed out, a net change of +9 holders.
  • The largest Amneal Pharmaceuticals buyer in Q3 2025 was BlackRock, an estimated $17.4M added.
  • The largest Amneal Pharmaceuticals seller in Q3 2025 was Millennium Management, an estimated $15.4M sold.

Based on aggregated 13F filings for Q3 2025.